Science-led
A research hub spanning human evidence, pediatric research, real-world evidence, and scientific publications.
Research philosophy
We prioritize measurable, reproducible evidence and transparent methodology.
Our work includes human clinical research, including children with treatment-resistant epilepsy.
More than a decade of accumulated treatment experience informs our development.
Research programs
Better Cann Pharmaceutical was among the early Israeli companies involved in multi-center clinical research involving children and adolescents with severe, treatment-resistant epilepsy.
View ResearchAn Israeli study of drug-resistant epilepsy evaluating a CBD-enriched sub-lingual oil formulation, complementing the company’s broader pediatric epilepsy research program.
View ResearchSince 2009, the company has accumulated real-world treatment experience across complex medical conditions, informing formulation development and continuity of care.
View Research